Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy - A role for genotyping in decision-making?

被引:25
作者
Wichter, T [1 ]
Breithardt, G [1 ]
机构
[1] Univ Klinkum Munster, Med Klin & Poliklin C, Dept Cardiol & Angiol, D-48129 Munster, Germany
关键词
D O I
10.1016/j.jacc.2004.11.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:409 / 411
页数:3
相关论文
共 10 条
[1]   Localization of a gene responsible for arrhythmogenic right ventricular dysplasia to chromosome 3p23 [J].
Ahmad, F ;
Li, DX ;
Karibe, A ;
Gonzalez, O ;
Tapscott, T ;
Hill, R ;
Weilbaecher, D ;
Blackie, P ;
Furey, M ;
Gardner, M ;
Bachinski, LL ;
Roberts, R .
CIRCULATION, 1998, 98 (25) :2791-2795
[2]   IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY IN PATIENTS WITH ARRHYTHMOGENIC RIGHT-VENTRICULAR CARDIOMYOPATHY, LONG QT SYNDROME, OR NO STRUCTURAL HEART-DISEASE [J].
BREITHARDT, G ;
WICHTER, T ;
HAVERKAMP, W ;
BORGGREFE, M ;
BLOCK, M ;
HAMMEL, D ;
SCHELD, HH .
AMERICAN HEART JOURNAL, 1994, 127 (04) :1151-1158
[3]   Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with Arrhythmogenic right ventricular cardiomyopathy/dysplasia [J].
Corrado, D ;
Leoni, L ;
Link, MS ;
Della Bella, P ;
Gaita, F ;
Curnis, A ;
Salerno, JU ;
Igidbashian, D ;
Raviele, A ;
Disertori, M ;
Zanotto, G ;
Verlato, R ;
Vergara, G ;
Delise, P ;
Turrini, P ;
Basso, C ;
Naccarella, F ;
Maddalena, F ;
Estes, NAM ;
Buja, G ;
Thiene, G .
CIRCULATION, 2003, 108 (25) :3084-3091
[4]   Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy [J].
Gerull, B ;
Heuser, A ;
Wichter, T ;
Paul, M ;
Basson, CT ;
McDermott, DA ;
Lerman, BB ;
Markowitz, SM ;
Ellinor, PT ;
MacRae, CA ;
Peters, S ;
Grossmann, KS ;
Michely, B ;
Sasse-Klaassen, S ;
Birchmeier, W ;
Dietz, R ;
Breithardt, G ;
Schulze-Bahr, E ;
Thierfelder, L .
NATURE GENETICS, 2004, 36 (11) :1162-1164
[5]   The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5) [J].
Hodgkinson, KA ;
Parfrey, PS ;
Bassett, AS ;
Kupprion, C ;
Drenckhahn, J ;
Norman, MW ;
Thierfelder, L ;
Stuckless, SN ;
Dicks, EL ;
McKenna, WJ ;
Connors, SP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) :400-408
[6]   Arrhythmogenic Right Ventricular Dysplasia: Clinical Results with Implantable Cardioverter Defibrillators [J].
Link M.S. ;
Wang P.J. ;
Haugh C.J. ;
Homoud M.K. ;
Foote C.B. ;
Costeas X.B. ;
Estes III N.A.M. .
Journal of Interventional Cardiac Electrophysiology, 1997, 1 (1) :41-48
[7]   Genetics of arrhythmogenic right ventricular cardiomyopathy status quo and future perspectives [J].
Paul, M ;
Schulze-Bahr, E ;
Breithardt, G ;
Wichter, T .
ZEITSCHRIFT FUR KARDIOLOGIE, 2003, 92 (02) :128-136
[8]   Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy [J].
Roguin, A ;
Bomma, CS ;
Nasir, K ;
Tandri, H ;
Tichnell, C ;
James, C ;
Rutberg, J ;
Crosson, J ;
Spevak, PJ ;
Berger, RD ;
Halperin, HR ;
Calkins, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (10) :1843-1852
[9]   Long term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias [J].
Tavernier, R ;
Gevaert, S ;
De Sutter, J ;
De Clercq, A ;
Rottiers, H ;
Jordaens, L ;
Fonteyne, W .
HEART, 2001, 85 (01) :53-56
[10]   Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy -: Single-center experience of long-term follow-up and complications in 60 patients [J].
Wichter, T ;
Paul, M ;
Wollmann, C ;
Acil, T ;
Gerdes, P ;
Ashraf, O ;
Tjan, TDT ;
Soeparwata, R ;
Block, M ;
Borggrefe, M ;
Scheld, HH ;
Breithardt, G ;
Böcker, D .
CIRCULATION, 2004, 109 (12) :1503-1508